leukotriene-b4 and Brucellosis

This study investigated the contribution of lipoxygenase (LOX) inhibitors, nordihydroguaiaretic acid (NDGA), tetra-

Topics: Animals; Brucella abortus; Brucellosis; Cytokines; Interleukin-10; Interleukin-12; Leukotriene B4; Lipoxygenase Inhibitors; Lipoxygenases; Masoprocol; Mice; Receptors, Leukotriene B4; Thromboxane A2; Tumor Necrosis Factor-alpha

Brucella abortus is a Gram-negative bacterium that infects humans and cattle, causing a chronic inflammatory disease known as brucellosis. A Th1-mediated immune response plays a critical role in host control of this pathogen. Recent findings indicate contrasting roles for lipid mediators in host responses against infections. 5-Lipoxygenase (5-LO) is an enzyme required for the production of the lipid mediators leukotrienes and lipoxins. To determine the involvement of 5-LO in host responses to B. abortus infection, we intraperitoneally infected wild-type and 5-LO-deficient mice and evaluated the progression of infection and concomitant expression of immune mediators. Here, we demonstrate that B. abortus induced the upregulation of 5-LO mRNA in wild-type mice. Moreover, this pathogen upregulated the production of the lipid mediators leukotriene B4 and lipoxin A4 in a 5-LO-dependent manner. 5-LO-deficient mice displayed lower bacterial burdens in the spleen and liver and less severe liver pathology, demonstrating an enhanced resistance to infection. Host resistance paralleled an increased expression of the proinflammatory mediators interleukin-12 (IL-12), gamma interferon (IFN-γ), and inducible nitric oxide synthase (iNOS) during the course of infection. Moreover, we demonstrated that 5-LO downregulated the expression of IL-12 in macrophages during B. abortus infection. Our results suggest that 5-LO has a major involvement in B. abortus infection, by functioning as a negative regulator of the protective Th1 immune responses against this pathogen.

Topics: Animals; Arachidonate 5-Lipoxygenase; Bacterial Load; Brucella abortus; Brucellosis; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Immunity, Innate; Injections, Intraperitoneal; Interferon-gamma; Interleukin-12; Leukotriene B4; Lipoxins; Liver; Macrophages; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Spleen; Th1 Cells